JP2022548270A5 - - Google Patents
Info
- Publication number
- JP2022548270A5 JP2022548270A5 JP2022516687A JP2022516687A JP2022548270A5 JP 2022548270 A5 JP2022548270 A5 JP 2022548270A5 JP 2022516687 A JP2022516687 A JP 2022516687A JP 2022516687 A JP2022516687 A JP 2022516687A JP 2022548270 A5 JP2022548270 A5 JP 2022548270A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- fxn
- human
- promoter
- acid construct
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962899953P | 2019-09-13 | 2019-09-13 | |
| US62/899,953 | 2019-09-13 | ||
| PCT/US2020/050551 WO2021050991A1 (en) | 2019-09-13 | 2020-09-11 | Compositions and methods for treatment of friedreich's ataxia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022548270A JP2022548270A (ja) | 2022-11-17 |
| JP2022548270A5 true JP2022548270A5 (cg-RX-API-DMAC7.html) | 2023-07-25 |
Family
ID=74865919
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022516687A Pending JP2022548270A (ja) | 2019-09-13 | 2020-09-11 | フリードライヒ運動失調症の治療のための組成物及び方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220211737A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4028027A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022548270A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020346914A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3151073A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021050991A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023077123A1 (en) * | 2021-11-01 | 2023-05-04 | University Of Florida Research Foundation, Incorporated | Aav-mediated therapies for vision loss associated with friedreich's ataxia |
| CN120417914A (zh) * | 2022-11-01 | 2025-08-01 | 普利维尔治疗公司 | 用于治疗弗里德赖希共济失调的组合物和方法 |
| WO2025157942A2 (en) * | 2024-01-23 | 2025-07-31 | Icm (Institut Du Cerveau Et De La Moelle Épinière) | Encapsulated engineered cells for treating a disease or condition affecting the nervous system |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3632923A1 (en) * | 2015-01-16 | 2020-04-08 | Voyager Therapeutics, Inc. | Central nervous system targeting polynucleotides |
| EP3286321A4 (en) * | 2015-04-24 | 2018-10-17 | University of Florida Research Foundation, Inc. | Aav vector for treatment of friedreich's ataxia |
| AU2016343979A1 (en) * | 2015-10-29 | 2018-05-10 | Voyager Therapeutics, Inc. | Delivery of central nervous system targeting polynucleotides |
| SG10201912763QA (en) * | 2015-11-05 | 2020-02-27 | Bamboo Therapeutics Inc | Modified friedreich ataxia genes and vectors for gene therapy |
| AU2017359342B2 (en) * | 2016-11-09 | 2022-02-17 | Intrexon Corporation | Frataxin expression constructs |
| US10780183B2 (en) * | 2017-06-19 | 2020-09-22 | Translate Bio, Inc. | Messenger RNA therapy for the treatment of Friedreich's ataxia |
| WO2019000093A1 (en) * | 2017-06-29 | 2019-01-03 | UNIVERSITé LAVAL | PLATINUM TALE AND USE THEREOF TO INCREASE THE EXPRESSION OF FRATAXIN |
| PL3697914T3 (pl) * | 2017-10-17 | 2023-10-16 | Fundació Institut D'investigació En Ciències De La Salut Germans Trias I Pujol | Wektory do leczenia ataksji friedreicha |
-
2020
- 2020-09-11 JP JP2022516687A patent/JP2022548270A/ja active Pending
- 2020-09-11 CA CA3151073A patent/CA3151073A1/en active Pending
- 2020-09-11 AU AU2020346914A patent/AU2020346914A1/en active Pending
- 2020-09-11 US US17/434,318 patent/US20220211737A1/en not_active Abandoned
- 2020-09-11 EP EP20863569.8A patent/EP4028027A4/en active Pending
- 2020-09-11 WO PCT/US2020/050551 patent/WO2021050991A1/en not_active Ceased